Showing results (1131-1140 of 2,107) with videos related to
Sort By:
Pageof 211
CNS Drugs|February 21, 2019
A Preliminary Study Evaluating the Safety and Efficacy of Bumetanide, an NKCC1 Inhibitor, in Patients with Drug-Resistant EpilepsyZeinab Gharaylou, Abbas Tafakhori, Elmira Agah, et al.CNS Drugs|February 13, 2021
Sex Differences in the Risk of Cutaneous Adverse Drug Reactions Induced by Antiseizure Medications: A Systematic Review and Meta-analysisIsraa Alfares, Muhammad Shahid Javaid, Zhibin Chen, et al.CNS Drugs|February 14, 2021
24-Hour Levodopa-Carbidopa Intestinal Gel: Clinical Experience and Practical RecommendationsSandeep Thakkar, Victor S C Fung, Aristide Merola, et al.CNS Drugs|March 8, 2021
Cognitive Outcomes with Sequential Escitalopram Monotherapy and Adjunctive Aripiprazole Treatment in Major Depressive Disorder: A Canadian Biomarker Integration Network in Depression (CAN-BIND-1) ReportTrisha Chakrabarty, Shane J McInerney, Ivan J Torres, et al.CNS Drugs|July 16, 2015
[(18)F]Florbetaben: a review in β-amyloid PET imaging in cognitive impairmentYahiya Y Syed, Emma DeeksCNS Drugs|July 20, 2015
Prevention studies in Alzheimer's disease: progress towards the development of new therapeuticsNicola Coley, Adeline Gallini, Sandrine AndrieuCNS Drugs|September 2, 2025
Genetic and Mechanistic Insights Inform Amyotrophic Lateral Sclerosis Treatment and Symptomatic Management: Current and Emerging Therapeutics and Clinical Trial Design ConsiderationsSavannah E Quigley, Kellen H Quigg, Stephen A GoutmanCNS Drugs|June 14, 2015
Diagnosis and Treatment of Toxoplasmosis of the CNS in Patients with AIDSC KatlamaCNS Drugs|June 14, 2015
Cognitive Adverse Effects of Antiepileptic Drugs : Incidence, Mechanisms and Therapeutic ImplicationsR Kälviäinen, M Äikiä, P J RiekkinenCNS Drugs|June 14, 2015
Comparative Review of Dopamine Receptor Agonists in Parkinson's DiseaseR J Uitti, J E AhlskogPageof 211